hedge fund managers

  • 21 Aug 2014 at 3:58 PM

Steve Cohen Betting On Steve Cohen

Now, people close to Cohen say he has quietly and methodically launched a multi-pronged effort to eventually make his full return to the hedge fund business, even if many legal experts say the odds are low that he will prevail. “I would say Steven Cohen’s chances are about as good as Michael Milken’s would be” for returning the securities business, said Columbia Law School professor John Coffee, referring to the tarnished junk bond pioneer. Still, Coffee added, “a lifetime ban allows you to reapply five years later for readmission,” meaning it’s not impossible. [FBN]

Would it have been nice to visit Channing and Jonah on the set of the third installment? Sure. Did a small part of him want to direct? Yes. Did he feel he could’ve brought a Queens school-yard authenticity to things? You betcha. But these are not the things that keep him up at night. Read more »

The last two years were just a warm-up. Read more »

  • 05 Aug 2014 at 3:30 PM

David Einhorn Could Use A Hand Here!

“We had a difficult time finding new investments this quarter,” he said today on a conference call discussing results at Greenlight Capital Re Ltd. (GLRE), the Cayman Islands-based reinsurer where he is chairman. “As the market continues to rise in the face of conflicting economic data, global unrest, and looming overdue Fed exit from quantitative easing we remain cautiously positioned.” [Bloomberg]

  • 05 Aug 2014 at 12:00 PM

Andrew Ross Sorkin Smells Something Fishy

Late last week, Botox-maker Allergan Inc sued Valeant Pharmaceuticals and Pershing Square, alleging the latter two had engaged in insider trading when Pershing bought $1 billion worth of Allergan shares ahead of a takeover offer by the hedge fund and Valeant. On the suggestion of wrongdoing, Valeant called with charges “baseless,” while Ackman stated in a press release that “This is a shameless attempt by Allergan to delay the shareholders’ fundamental right to call a special meeting and vote their shares. Allergan is threatened by our progress toward calling the special meeting. This scorched-earth approach is further evidence of the board’s and management’s further entrenchment.”

Not entirely convinced? Dealbook‘s Andrew Ross Sorkin, who in his column today says WAIT JUST A SECOND, PEOPLE. Read more »

  • 04 Aug 2014 at 1:29 PM

A Lot Of People Owe Ray Dalio An Apology

Last Friday was the Bridgwater founder’s birthday– did you wish him a happy or even pause to commemorate the moment he came into this world? Or did it go by unnoticed, unremarked? Start thinking now about how you’re going to do better next year. At three-days out, we’ve already missed the window for coming in with a belated phone call or text. Read more »

  • 31 Jul 2014 at 12:02 PM

Bill Ackman Is Sorry You Got Your Hopes Up

Remember, last week, when Bill Ackman gave a presentation about Herbalife, the company he is shorting? And the day prior, went on CNBC to announce the event, telling viewers they would learn “why Herbalife is going to collapse”? And described the presentation as “the most important” one of his career? And back at Pershing Square, told his advisors “fuck the webcast, I want to look into people’s eyes,” upgrading the talk to a live show at the AXA building in midtown? And made the case that, despite having spent hundreds of hours publicly excoriating Herbalife already, this was the event that people needed to see? And noted that he was “raising expectations” but “would not disappoint”? He realizes now it’s possible he should’ve dialed down the enthusiasm just a bit. Read more »